Orbimed Advisors Llc sold $12.7M of Enliven Therapeutics (ELVN)

Executed Jun 15, disclosed Jun 17, 2 days later.

Value, as filed

$12.7M

281,408 sh across 2 lots

Executed

Jun 15

the trade date, as filed

Disclosed

Jun 17

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 15 Form 4 reports as a reporting entity in the trailing twelve months (7 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 7 priced purchase filings, the average 21-session return was +16.9% from execution and +18.9% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

ELVN

Enliven Therapeutics, Inc. ELVN · Healthcare · 61 filings in 24 months ticker →

Healthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Orbimed Advisors Llc in ELVN

ELVNSALE Enliven Therapeutics, Inc. $38.9M
858,646 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET